Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114276) titled 'Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients' on Aug. 4.

Study Type: Observational [Patient Registry]

Primary Sponsor: Taipei Medical University

Condition: Chemotherapy Side Effects Machine Learning Acute Kidney Injury Acute Kidney Disease

Intervention: Other: Machine learning models predictions of acute kidney injury and acute kidney disease

Recruitment Status: Recruiting

Date of First Enrollment: October 30, 2023

Target Sample Size: 110

Countries of Recruitment: Taiwan

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114276

P...